The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey
|
|---|---|
| Published in |
Frontiers in oncology, June 2023
|
| DOI | 10.3389/fonc.2023.1151733 |
| Pubmed ID | |
| Authors |
Çağlar Ünal, Tolga Özmen, Çetin Ordu, Kezban Nur Pilanci, Ahmet Serkan İlgün, Erhan Gökmen, Elvina Almuradova, Mustafa Özdoğan, Nilüfer Güler, Cihan Uras, Halil Kara, Orhan Demircan, Selver Işık, Gül Alço, Pınar Saip, Esra Aydın, Tomris Duymaz, Filiz Çelebi, Kanay Yararbaş, Gursel Soybir, Vahit Ozmen |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 6 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 1 | 17% |
| Student > Ph. D. Student | 1 | 17% |
| Researcher | 1 | 17% |
| Unknown | 3 | 50% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 2 | 33% |
| Nursing and Health Professions | 1 | 17% |
| Unknown | 3 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 July 2023.
All research outputs
#20,718,702
of 26,316,370 outputs
Outputs from Frontiers in oncology
#9,724
of 22,971 outputs
Outputs of similar age
#268,772
of 383,813 outputs
Outputs of similar age from Frontiers in oncology
#337
of 1,058 outputs
Altmetric has tracked 26,316,370 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,971 research outputs from this source. They receive a mean Attention Score of 3.2. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 383,813 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,058 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.